Sector Image

About Us

Advent Venture Partners is one of Europe’s most established venture and growth capital firms, investing in world-class technology and life sciences businesses. We are dedicated to executing a balanced investment strategy delivering consistent returns for our investors.

We seek out remarkable companies that want a pragmatic and well-connected partner by their side. Our collective experience with hundreds of businesses is that the best results come when great teams have a clear and capital efficient path to value creation. By applying our domain expertise, entrepreneurial experience and corporate finance know-how, we make sure our portfolio companies have actionable plans that deliver value in the real world.

One of the clear leaders in European life sciences venture capital, Advent’s life sciences team has a first-class track record of successful company creation, and venture investing in innovation-driven and best-in-class companies in Europe and the US. Some of our investments include: PowderMed, a therapeutic DNA vaccine company sold to Pfizer; Thiakis, an obesity treatment company acquired by Wyeth Pharmaceuticals for £100 million; Speciality European Pharma a urology focused speciality pharmaceutical company for the European market; EUSA Pharma, a rapidly growing transatlantic speciality pharmaceutical company focused on late-stage oncology, pain control and critical care products; and, Algeta, an oncology company developing treatments for bone metastases and disseminated tumour types.

Top tier growth equity and venture investors, Advent’s technology team backs leading European technology-driven businesses in Internet, digital media, software and services, telecoms, and cleantech. Some of our investments include: Cartesis, a growth capital software investment acquired by Business Objects for $300 million; Qype, Europe’s largest local search and review site; The Foundry, a buyout of the Academy Award winning global visual effects software vendor for the post-production industry; and Echovox, the company behind the Zong mobile payments service.